| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 439 |
| 1 | TACROLIMUS | 353 |
| 2 | RIBAVIRIN | 342 |
| 3 | RITUXIMAB | 333 |
| 4 | FUROSEMIDE | 311 |
| 5 | ASPIRIN | 309 |
| 6 | ASPIRIN 325 MG | 304 |
| 7 | ASPIRIN 81 MG | 304 |
| 8 | PREDNISOLONE | 297 |
| 9 | PREDNISOLONE ORAL | 297 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEFOTETAN DISODIUM | 17 | 0.1518 |
| 1 | CEFOTETAN | 20 | 0.1504 |
| 2 | APOMORPHINE HYDROCHLORIDE | 35 | 0.0207 |
| 3 | DASPONE | 170 | 0.0171 |
| 4 | DAPSONE GEL, 5% | 170 | 0.0171 |
| 5 | RASBURICASE | 41 | 0.0166 |
| 6 | METHYLENE BLUE | 25 | 0.0158 |
| 7 | DAPSONE | 171 | 0.0157 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 130 | 0.0156 |
| 9 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 67 | 0.0147 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1168 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 750 |
| 2 | Platinum-based Drug [EPC] | 449 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 371 |
| 4 | Proton Pump Inhibitor [EPC] | 370 |
| 5 | Nucleoside Analog Antiviral [EPC] | 358 |
| 6 | Loop Diuretic [EPC] | 335 |
| 7 | Alkylating Drug [EPC] | 313 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 311 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 309 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sulfone [EPC] | 171 | 0.0157 |
| 1 | Human Immunoglobulin G [EPC] | 151 | 0.0072 |
| 2 | Uric Acid-specific Enzyme [EPC] | 27 | 0.0070 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 131 | 0.0068 |
| 4 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 4 | 0.0053 |
| 5 | Interferon gamma Blocker [EPC] | 1 | 0.0042 |
| 6 | Nucleoside Analog Antiviral [EPC] | 358 | 0.0042 |
| 7 | Tricyclic Antidepressant [EPC] | 2 | 0.0042 |
| 8 | Pyruvate Kinase Activator [EPC] | 5 | 0.0038 |
| 9 | Monobactam Antibacterial [EPC] | 10 | 0.0037 |